Skip to main content
OpenTrials
Completed

NCT Number: NCT05246969

Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage

The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Subarachnoid Hemorrhage Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Hemorrhage Infections Inflammation Intracranial Hemorrhages Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Sepsis Bacterial Sepsis Syndrome Sepsis, Severe Shock Subarachnoid Hemorrhage, Aneurysmal Systemic Inflammatory Response Syndrome Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Frankfurt

Niederrad, Hesse, 60590, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS >2).

Exclusion criteria

children under the age of 18 years Patients with minor subarachnoid hemorrhage < WFNS stage 2.

Treatment and study plan

Sepsis detection

Other

The aim of the study was to observe whether the treating physicians were able to detect sepsis by strictly applying the recommended SOFA score.

Primary outcomes

  1. Sepsis SOFA positive

    Time frame: up to 2 months

    Sepsis correctly detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

  2. Sepsis SOFA negative

    Time frame: up to 2 months

    Sepsis not detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

Sponsors and collaborators

Lead sponsor

Goethe University

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2022
First posted
Feb 18, 2022
Registry last updated
Mar 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.